Divalproex Sodium
Product Images NDC 54868-6088

5 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 54868-6088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Divalproex 01)

Chemical Structure (Divalproex 01)
Chemical structure of divalproex sodium showing the molecular arrangement including sodium ion and carbon chains as depicted in the diagram.*
FDA Label Image

Figure (Divalproex 02)

Figure (Divalproex 02)
A line graph comparing the percentage reduction in CPS rate versus the percentage of patients for Divalproex Sodium Delayed Release Tablets and Placebo. The vertical axis ranges from -100% to 100%, indicating worsening to improvement, while the horizontal axis shows the percentage of patients from 0 to 100.*
FDA Label Image

Figure (Divalproex 03)

Figure (Divalproex 03)
A cumulative distribution plot showing the percentage reduction in Clinical Global Impression (CGI) scale scores versus the percentage of patients for two groups: those treated with high dose Divalproex Sodium delayed release tablets and those with low dose Divalproex Sodium delayed release tablets. The y-axis indicates improvement or worsening, and the x-axis shows the percentage of patients, with curves depicting the response distribution for each dosage group.*
FDA Label Image

Figure (Divalproex 04)

Figure (Divalproex 04)
A bar graph comparing placebo with Divalproex Sodium Extended Release Tablets. The graph shows values on the vertical axis, with Divalproex Sodium displaying a higher bar reaching 1.2 compared to placebo at 0.6. The chart includes a statistical significance marker with p=0.006.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle)

Principal Display Panel (500 mg Tablet Bottle)
Divalproex Sodium 500 mg extended-release tablets label from Physicians Total Care, Inc. The label indicates 60 tablets per bottle. It includes dosing instructions, proper storage at room temperature, a caution about federal law prohibiting dispensing without prescription, and a lot number with expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.